Patents by Inventor Ruth CALDWELL

Ruth CALDWELL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240067949
    Abstract: Pathological retinal neovascularization is a common micro-vascular complication in several retinal diseases including retinopathy of prematurity (ROP), diabetic retinopathy, age related macular degeneration and central vein occlusion. Disclosed herein are compositions and methods useful for the treatment or prevention of retinal neovascularization and related diseases in a subject in need thereof. Exemplary methods include administering a composition including PEGylated arginase 1 to a subject in need thereof to promote reparative angiogenesis and decrease retinal neovascularization in the eye.
    Type: Application
    Filed: July 11, 2023
    Publication date: February 29, 2024
    Applicants: Augusta University Research Institute, Inc., The US Government as Represented by the Department of Veterans Affairs
    Inventor: Ruth CALDWELL
  • Publication number: 20210340516
    Abstract: Pathological retinal neovascularization is a common micro-vascular complication in several retinal diseases including retinopathy of prematurity (ROP), diabetic retinopathy, age-related macular degeneration and central vein occlusion. Disclosed herein are compositions and methods useful for the treatment or prevention of retinal neovascularization and related diseases in a subject in need thereof. Exemplary methods include administering a composition including PEGylated arginase 1 to a subject in need thereof to promote reparative angiogenesis and decrease retinal neovascularization in the eye.
    Type: Application
    Filed: April 29, 2021
    Publication date: November 4, 2021
    Inventor: Ruth CALDWELL